Beta-blocker use after MI and preserved ejection fraction offers no benefit: REDUCE-AMI trial
Sweden: Findings from the REDUCE-AMI published in The New England Journal of Medicine have shown no benefit of beta-blockers in revascularized patients with normal ejection fraction (EF) after myocardial infarction (MI). The study revealed that long-term beta-blocker treatment did not result in a lower risk of the composite primary end point of death from any […]